egtazic acid has been researched along with Acute Confusional Senile Dementia in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, J; Li, D; Li, Y; Liu, W; Ruan, Q; Wang, M; Wu, K; Xia, J; Yang, D; Zheng, Z | 1 |
| Ham, S; Han, JS; Han, S; Jung, YK; Kim, J; Lee, KW; Lee, S; Park, JHY; Shim, I | 1 |
| Aronica, E; Canonico, PL; Genazzani, AA; Grolla, AA; Iyer, A; Lim, D; Ronco, V | 1 |
| Chen, M; Nguyen, HT | 1 |
| Bali, J; Birnbaum, JH; Nitsch, RM; Rajendran, L; Tackenberg, C | 1 |
| Glicksman, MA; Huang, MM; Michaelis, ML; Ni, J; Schuman, ER; Seyb, KI | 1 |
| Borutaitė, V; Cižas, P; Jekabsonė, A; Morkūnienė, R | 1 |
| Choi, SH; Hwang, SH; Jang, CG; Kang, J; Kim, HC; Kim, HJ; Kwon, SH; Lee, BH; Lee, JH; Nah, SY; Shin, EJ; Shin, TJ | 1 |
| Ferreira, A; Kelly, BL | 1 |
| Cho, HJ; Huh, K; Jin, SM; Mook-Jung, I; Youn, HD | 1 |
| Caragounis, A; Crouch, PJ; Du, T; Filiz, G; Price, KA; White, AR | 1 |
| Haley, BE; Pendergrass, JC | 1 |
| Emmerling, MR; Spiegel, K; Watson, MD | 1 |
| Atwood, CS; Beyreuther, K; Bush, AI; Cherny, RA; Fairlie, DP; Huang, X; Legg, JT; Masters, CL; McLean, CA; Tanzi, RE | 1 |
| Carlson, CD; Cox, LM; Gitter, BD; May, PC | 1 |
| Friedlander, RM; Kwon, YT; Lee, MS; Li, M; Peng, J; Tsai, LH | 1 |
| Aosaki, T; Miura, M; Nakajima, M; Shirasawa, T | 1 |
2 review(s) available for egtazic acid and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
The role of metals in modulating metalloprotease activity in the AD brain.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Brain; Cell Culture Techniques; Chelating Agents; Clioquinol; Copper; Disease Models, Animal; Egtazic Acid; Enzyme Activation; ErbB Receptors; Humans; Intracellular Space; Matrix Metalloproteinases, Secreted; Mitogen-Activated Protein Kinases; Plaque, Amyloid; Proline; Thiocarbamates; Trace Elements; Zinc | 2008 |
Inhibition of brain tubulin-guanosine 5'-triphosphate interactions by mercury: similarity to observations in Alzheimer's diseased brain.
Topics: Administration, Inhalation; Alzheimer Disease; Animals; Binding Sites; Brain; Chelating Agents; Edetic Acid; Egtazic Acid; Glutamic Acid; Guanosine Triphosphate; Humans; Isotope Labeling; Mercury; Microtubules; Nucleotides; Rats; Tubulin | 1997 |
15 other study(ies) available for egtazic acid and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Suppression of Selective Voltage-Gated Calcium Channels Alleviates Neuronal Degeneration and Dysfunction through Glutathione S-Transferase-Mediated Oxidative Stress Resistance in a
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcium; Calcium Channels; Egtazic Acid; Nimodipine; Oxidative Stress; Ryanodine Receptor Calcium Release Channel | 2022 |
Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Calcium; Calcium Channels; Capsaicin; Chelating Agents; Disease Models, Animal; Egtazic Acid; Hippocampus; Learning; Memory Disorders; Mice; Mice, Knockout; Nociceptors; tau Proteins; TRPV Cation Channels | 2020 |
Amyloid beta deregulates astroglial mGluR5-mediated calcium signaling via calcineurin and Nf-kB.
Topics: Adaptor Proteins, Signal Transducing; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Newborn; Astrocytes; B-Cell CLL-Lymphoma 10 Protein; Boron Compounds; Calcineurin; Calcium; Calcium Signaling; Cells, Cultured; Chelating Agents; Egtazic Acid; Enzyme Inhibitors; Female; Hippocampus; Humans; Male; Neoplasm Proteins; NF-kappa B; Nucleocytoplasmic Transport Proteins; Peptide Fragments; Rats; Receptor, Metabotropic Glutamate 5; Up-Regulation | 2013 |
High-energy compounds mobilize intracellular Ca2+ and activate calpain in cultured cells: is calpain an energy-dependent protease?
Topics: Acetyl Coenzyme A; Adenosine Triphosphate; Alzheimer Disease; Calcium; Calpain; Cell Line, Tumor; Chelating Agents; Cysteine Proteinase Inhibitors; Dipeptides; Egtazic Acid; Extracellular Space; Glutamic Acid; Humans; Intracellular Space; Nicotine; Nicotinic Agonists; Phosphocreatine; Phosphoenolpyruvate; Rotenone; Uncoupling Agents | 2014 |
Calcium flux-independent NMDA receptor activity is required for Aβ oligomer-induced synaptic loss.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Calcium; Dendritic Spines; Dizocilpine Maleate; Egtazic Acid; Glutamic Acid; GTP-Binding Proteins; Hippocampus; Memantine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neuroprotective Agents; p38 Mitogen-Activated Protein Kinases; Pertussis Toxin; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Valine | 2015 |
Identification of small molecule inhibitors of beta-amyloid cytotoxicity through a cell-based high-throughput screening platform.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Calcium; Calpain; Cell Death; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Egtazic Acid; Humans; Luminescence; Mass Screening; Neurodegenerative Diseases; Time Factors | 2008 |
Prevention of amyloid-beta oligomer-induced neuronal death by EGTA, estradiol, and endocytosis inhibitor.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; beta-Cyclodextrins; Cells, Cultured; Cerebellum; Egtazic Acid; Endocytosis; Estradiol; Microscopy, Fluorescence; Necrosis; Neurons; Propidium; Rats; Rats, Wistar | 2011 |
Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer's disease-related neuropathies: involvement of non-amyloidogenic processing.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Brain; Calcium; Calcium-Binding Proteins; Cell Survival; Disease Models, Animal; Donepezil; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Inhibitors; Glycoproteins; Humans; Indans; Isoxazoles; Ligands; Maze Learning; Memory Disorders; Metalloproteases; Mice; Mice, Transgenic; Microfilament Proteins; Mutation; Neuroblastoma; Nootropic Agents; Panax; Peptide Fragments; Phytotherapy; Piperidines; Plant Proteins; Presenilin-1; Propionates; Protein Binding; Receptors, Lysophosphatidic Acid; Signal Transduction; Time Factors; Transfection | 2012 |
beta-Amyloid-induced dynamin 1 degradation is mediated by N-methyl-D-aspartate receptors in hippocampal neurons.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Calcium; Calcium Channels, L-Type; Calpain; Cells, Cultured; Dynamin I; Egtazic Acid; Enzyme Activation; Hippocampus; Homeostasis; Rats; Receptors, N-Methyl-D-Aspartate; Synapses | 2006 |
Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling.
Topics: Active Transport, Cell Nucleus; Aging; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Calcineurin; Calcineurin Inhibitors; Calcium; Calcium Signaling; Cells, Cultured; Chelating Agents; Cyclosporine; Disease Models, Animal; DNA-Binding Proteins; Egtazic Acid; Enzyme Activation; Humans; Ionophores; Mice; Neuroblastoma; NFATC Transcription Factors; Promoter Regions, Genetic; Up-Regulation | 2008 |
Inhibiting the formation of classical C3-convertase on the Alzheimer's beta-amyloid peptide.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Chelating Agents; Coloring Agents; Complement Activation; Complement C1 Inactivator Proteins; Complement C1q; Complement C3-C5 Convertases; Complement C3a; Complement C4; Congo Red; Egtazic Acid; Humans; Nerve Degeneration; Protease Inhibitors | 1997 |
Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Chelating Agents; Copper; Egtazic Acid; Ethylenediamines; Humans; Phenanthrolines; Water; Zinc | 1999 |
Human amylin stimulates inflammatory cytokine secretion from human glioma cells.
Topics: Aging; Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Astrocytoma; Brain Neoplasms; Calcium; Cytokines; Dose-Response Relationship, Drug; Drug Synergism; Egtazic Acid; Humans; Interleukin-1; Islet Amyloid Polypeptide; Neoplasm Proteins; Nerve Degeneration; Protein Structure, Secondary; Rats; Recombinant Proteins; Sequence Homology, Amino Acid; Species Specificity; Tumor Cells, Cultured | 2000 |
Neurotoxicity induces cleavage of p35 to p25 by calpain.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Animals; Calcium; Calpain; Cells, Cultured; Egtazic Acid; Glutamic Acid; Hydrogen Peroxide; Ionomycin; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Nerve Tissue Proteins; Neurons; Peptide Fragments; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Recombinant Proteins | 2000 |
Deficiency of presenilin-1 increases calcium-dependent vulnerability of neurons to oxidative stress in vitro.
Topics: Alzheimer Disease; Animals; Calcium; Cell Survival; Cells, Cultured; Cerebral Cortex; Chelating Agents; Egtazic Acid; Glutamic Acid; Hippocampus; Humans; Immunoblotting; Immunohistochemistry; Membrane Proteins; Mice; Mice, Transgenic; Neurons; Oxidative Stress; Peroxides; Presenilin-1 | 2001 |